Catalyst Pharmaceutical Inc (CPRX) Com Stk USD0.001

Sell:$23.76Buy:$24.00$0.33 (1.36%)

Prices delayed by at least 15 minutes
Sell:$23.76
Buy:$24.00
Change:$0.33 (1.36%)
Prices delayed by at least 15 minutes
Sell:$23.76
Buy:$24.00
Change:$0.33 (1.36%)
Prices delayed by at least 15 minutes

Company Information

About this company

Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing medicines for patients living with rare and difficult-to-treat diseases. The Company markets three drug products: FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone). FIRDAPSE is a treatment for people six years of age or older living with Lambert-Eaton myasthenic syndrome (LEMS). The Company, through its sub-licensee, also offers FIRDAPSE in Canada and Japan. FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older. AGAMREE is a corticosteroid with a structure that retains the potent anti-inflammatory effects of traditional corticosteroids used in Duchenne muscular dystrophy.

Key people

Richard J. Daly
Chief Executive Officer, Director
Michael Wayne Kalb
Chief Financial Officer, Executive Vice President, Treasurer
Steven R. Miller
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
Jeffrey Del Carmen
Executive Vice President, Chief Commercial Officer
Brian D. Elsbernd
Chief Compliance Officer, Chief Legal Officer
Gary Ingenito
Chief Medical Officer and Regulatory Officer
Preethi Sundaram
Chief Strategy Officer
Patrick James Mcenany
Non-Executive Chairman of the Board
Charles B. O'Keeffe
Lead Independent Director
Donald A. Denkhaus
Independent Director
Molly Harper
Independent Director
Tamar Thompson
Independent Director
Click to see more

Key facts

  • EPIC
    CPRX
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US14888U1016
  • Market cap
    $3.00bn
  • Employees
    181
  • Shares in issue
    121.45m
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.